Zurich Cantonal Bank
TNGX icon

Zurich Cantonal Bank’s Tango Therapeutics TNGX Stock Holding History

Zurich Cantonal Bank’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
10,647
+6,180
+138% +$86K ﹤0.01% 2211
2025
Q4 		$39.6K Buy
4,467
+4,464
+148,800% +$38.5K ﹤0.01% 2446
2025
Q3 		$25 Hold
3
– – ﹤0.01% 2545
2025
Q2 		$15 Hold
3
– – ﹤0.01% 2556
2025
Q1 		$4 Sell
3
-13,491
-100% -$33.1K ﹤0.01% 2623
2024
Q4 		$41.7K Sell
13,494
-332
-2% -$1.54K ﹤0.01% 2566
2024
Q3 		$106K Hold
13,826
– – ﹤0.01% 2401
2024
Q2 		$119K Sell
13,826
-51
-0.4% -$394 ﹤0.01% 2307
2024
Q1 		$110K Sell
13,877
-25
-0.2% -$268 ﹤0.01% 2358
2023
Q4 		$138K Buy
13,902
+11,829
+571% +$103K ﹤0.01% 2288
2023
Q3 		$23.3K Sell
2,073
-685
-25% -$4.18K ﹤0.01% 2696
2023
Q2 		$9.16K Sell
2,758
-749
-21% -$2.69K ﹤0.01% 2749
2023
Q1 		$13.9K Buy
+3,507
New +$20.4K ﹤0.01% 2784

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Zurich Cantonal Bank's TNGX Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Tango Therapeutics (TNGX) stake by 138% in Q1 2026, buying an estimated $86K and bringing the position to 10,647 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Zurich Cantonal Bank first reported a position in TNGX in Q1 2023 and has held it in 13 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Zurich Cantonal Bank held 10,647 shares of Tango Therapeutics worth $223K as of Q1 2026.
  • Zurich Cantonal Bank bought 6,180 Tango Therapeutics shares in Q1 2026, an estimated $86K.
  • Tango Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2211 holding.
  • Zurich Cantonal Bank first reported a position in Tango Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.